PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

The Cooper Companies, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from The Cooper Companies, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Debt due within a year is covered 16.9 times by its yearly operating cash. Higher than 88% of Healthcare companies in United States.

Where $100 of sales goes

$83Operating costs$2.4Interest$9.2Net profit$0.0Paid as dividends

Latest year (Oct 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$199

Over the last 3 years, every $100 of reported profit came with $199 of operating cash.

Higher than 77% of Healthcare companies in United States.

Self-Funding Ratio

1.8×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.8 times.

Higher than 73% of Healthcare companies in United States.

Cash Locked Ratio

$34

For every $100 of sales, $34 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $28 tied up three years earlier.

More money tied up than 73% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 1/3

Sales grew in 3 of the last 3 years; profit grew in 1 of 3.

Steadier than 69% of Healthcare companies in United States.

Growth Efficiency Ratio

−$1

Sales grew 24% in 3 years, but profit fell: $1 less profit per $100 of extra sales.

Lower than 69% of Healthcare companies in United States.

Asset Productivity Ratio

+24% / +8%

In 3 years sales changed by +24% while total assets changed by +8%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

16.9×

Debt due within a year is covered 16.9 times by its yearly operating cash.

Higher than 88% of Healthcare companies in United States.

Cash Cushion Ratio

−21%

Debt, after subtracting cash, equals 21% of its market value (net debt).

Lower than 84% of Healthcare companies in United States.

Tangible Assets Ratio

56%

Of every $100 the company owns, $56 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 73% of Healthcare companies in United States.

Tangible Net Worth Ratio

34%

Of every $100 of net worth, $34 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 60% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

−1%

Share count fell 1% in 3 years (buybacks), so each share's slice of the company became larger. Dividends paid equalled 0% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

The Cooper Companies, Inc. owes $0.34 for every $1 it owns. Net profit fell 4% in the year to Oct 2025, and shrank 1% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Oct 2025.

P/E ratio

21.0

Investors pay $21.0 for every $1 of The Cooper Companies, Inc.'s yearly profit, lower than 61% of Healthcare companies in United States.

P/B ratio

1.40

The share price is 1.40 times The Cooper Companies, Inc.'s book value per share, lower than 69% of Healthcare companies in United States.

Market cap

$11.6 B

The total market value of all of The Cooper Companies, Inc.'s shares at today's price (share price × number of shares), larger than 91% of Healthcare companies in United States. PosiCap size class: Tito Cap.

Net worth (book value)

$8.3 B

What The Cooper Companies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).

Book value per share

$43.80

Net worth divided by the number of shares. The share price of $61.21 is 1.4 times this, which is the P/B above.

Return on equity (ROE)

6.8%

The Cooper Companies, Inc. earned 6.8% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.

Owes vs Owns

0.34×

The Cooper Companies, Inc. owes $0.34 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.

Dividend yield

None

The Cooper Companies, Inc. does not currently pay a dividend.

Revenue growth

+5%

Revenue rose 5% in the year to Oct 2025, and grew 7% a year on average over 3 years.

Profit growth

-4%

Net profit fell 4% in the year to Oct 2025, and shrank 1% a year on average over 3 years.

Profit margin

9.2%

The Cooper Companies, Inc. keeps $9 of every $100 of revenue as net profit.

Cash quality

2.1×

Cash from The Cooper Companies, Inc.'s business was 2.1× its reported profit in the year to Oct 2025 — its profit turned into cash.

Interest cover

6.8×

The Cooper Companies, Inc.'s operating profit covered its interest costs 6.8 times in the year to Oct 2025.

Cash vs debt

Net debt

The Cooper Companies, Inc. had $2.4 B more debt than cash (net debt) at Oct 2025.

Questions

What is The Cooper Companies, Inc.'s P/E ratio?

Investors pay $21.0 for every $1 of The Cooper Companies, Inc.'s yearly profit, lower than 61% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For The Cooper Companies, Inc.: $11.6 B ÷ $8.3 B (31 Jul 2026) = 1.4.

What is The Cooper Companies, Inc.'s return on equity?

The Cooper Companies, Inc. earned 6.8% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.

How much does The Cooper Companies, Inc. owe compared with what it owns?

The Cooper Companies, Inc. owes $0.34 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.

Does The Cooper Companies, Inc. pay a dividend?

No. The Cooper Companies, Inc. does not currently pay a dividend.

Is The Cooper Companies, Inc.'s revenue growing?

Revenue rose 5% in the year to Oct 2025, and grew 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.